1.	Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115AM1)(COMPLETED) Phase: Phase IV Type: Supportive care Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: P05115, EudraCT No. 2007-003148-31, NCT00686543
2.	Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)(COMPLETED) Phase: Phase III Type: Supportive care Status: Completed Age: 13 and over Sponsor: Pharmaceutical / Industry Protocol IDs: P01899, NCT00044486
3.	Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095) (COMPLETED) Phase: Phase III Type: Supportive care Status: Completed Age: 13 to 65 Sponsor: Pharmaceutical / Industry Protocol IDs: P02095, yes, NCT00034632
4.	Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC) Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: 2007-0020, NCT00750737
5.	Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care Status: Closed Age: Over 18 Sponsor: Other Protocol IDs: 2008-0793, NCT00936117